GSK plc’s (GSK) fourth-quarter results beat forecasts, with specialty medicines up 17%
GSK plc (NYSE:GSK) is among the The best undervalued European stocks to buy now.. On February 4, GSK plc (NYSE:GSK) announced fourth-quarter earnings that topped analyst estimates on several important metrics. Earnings per share for the quarter were $0.6989, 9.58% higher than the forecast of $0.6378. Revenue also beat forecasts, reaching $11.81 billion versus $11.36…